Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia

NCT02502565 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2018-06-19

No results posted yet for this study

Summary

An observational study to evaluate the prevalence of US changes of gout in the joints and tendons of patients with different degrees of asymptomatic hyperuricemia. The investigators' findings may support the extension of the spectrum of urate disease, and define a subset of patients that may benefit from early urate-lowering therapy.

Conditions

  • Hyperuricemia

Interventions

OTHER

Uric acid level

Sponsors & Collaborators

  • Howard University

    collaborator OTHER
  • AstraZeneca

    collaborator INDUSTRY
  • Washington D.C. Veterans Affairs Medical Center

    lead FED

Principal Investigators

  • Gail S Kerr, MD, FRCP · Washington VAMC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2019-01-31
Completion
2019-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02502565 on ClinicalTrials.gov